A systematic review and meta‐analysis of observational studies of the association between the use of incretin‐based therapies and the risk of pancreatic cancer - Hidayat, Khemayanto; Zhou, Ying‐Yi; Du, Hong‐Zhen; Qin, Li‐Qiang; Shi, Bi‐Min; Li, Zeng‐Ning (Pharmacoepidemiology and drug safety, 2023)
Keywords: Antidiabetics; Bias; Clinical medicine; Clinical trials; diabetes; Diabetes mellitus; dipeptidyl peptidase‐4 inhibitors; Dipeptidyl-Peptidase IV Inhibitors - adverse effects; GLP-1 receptor agonists; Glucagon; glucagon‐like peptide‐1 receptor agonists; Humans; Hypoglycemic Agents - adverse effects; incretin; Incretins - adverse effects; Insulin; Meta-analysis; Observational studies; Pancreatic cancer; Pancreatic Neoplasms - chemically induced; Risk assessment; Systematic review; dipeptidyl peptidase-4 inhibitors; pancreatic cancer; diabetes; incretin; glucagon-like peptide-1 receptor agonists